CG Oncology, Inc. (CGON)
Market Open
1 Sep, 19:41
NASDAQ (NGS) NASDAQ (NGS) Primary $
75. 97
+0.81
+1.078%
$
6.56B Market Cap
- P/E Ratio
- Div Yield
416,109 Volume
- Eps
$ 75.16
Previous Close 
Want to track CGON and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CG Oncology, Inc. (CGON) Statistics
Valuation metrics
Market Cap 6.56B
Enterprise value 6.55B
Trailing P/E (ttm) -27.53
Forward P/E -
PEG ratio 0.72
Price/Sales (ttm) 1,052.82
Price/Book (mrq) 6.37
Enterprise Value/Revenue 1,051.08
Enterprise Value/EBITDA -29.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 612.55K
Average volume (90 days) 1.42M
Price summary
52-Week low 26.25
52-Week high 80.97
Beta -
50-Day moving average 72.13
200-Day moving average 64.78
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -36.03%
Operating margin -40.56%
Operational effectiveness
Return on assets -0.21%
Return on equity -0.25%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.54
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.66
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 22.22%
Book value per share (mrq) 11.67
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
